What is 0.01% Atropine Sulfate Eye Drops? How does it help control myopia?

0.01% Atropine Sulfate Eye Drops-EIKANCE is a drug commonly used to prevent and control myopia in children. Its main ingredient is atropine sulfate, an anticholinergic drug that relaxes the eye muscles by interfering with ciliary muscle contraction, thereby slowing down the growth of the axial length of the eyeball. As the problem of myopia in children becomes increasingly serious, atropine sulfate eye drops have become a common treatment method in the field of ophthalmology to control myopia.

The principle of action of the drug is based on the effect of atropine sulfate on the eyes, in particular its inhibitory effect on the ciliary muscle. The ciliary muscle plays an important role in adjusting the focusing function of the eye, and atropine sulfate reduces the adjustment ability of the eyeball by inhibiting the activity of the ciliary muscle. Although it cannot directly change the refractive power of the eye, long-term use can effectively slow down the increase in axial length, thereby effectively slowing down the progression of myopia. This is especially important for children because their eyes are still developing and myopia changes rapidly.

0.01%Atropine sulfate eye drops are mostly used in clinical practice for teenagers aged 6 to 18 years old, especially those whose myopia is increasing rapidly. Research shows that atropine sulfate eye drops with a concentration of 0.01% has fewer side effects and can effectively control the progression of myopia. Compared with other higher-concentration atropine eye drops, 0.01%atropine sulfate has milder side effects, usually manifesting as mild eye irritation or short-term pupil dilation, and these adverse reactions are usually relatively controllable.

Although0.01%Atropine Sulfate Eye Drops are effective in controlling the progression of myopia, but they still need to be used under the guidance of a professional doctor. Doctors will decide whether to use this drug based on the patient's degree of myopia, age and eye health. During long-term use, regular eye examinations are required to ensure the efficacy of the drug and to deal with possible side effects in a timely manner. Through scientific and reasonable medication, combined with good eye habits, children can effectively delay the progression of myopia.

Reference materials:https://www.medsafe.govt.nz/profs/datasheet/e/EikanceEyeDrops.pdf